HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Buying $100 In HQY: If an investor had bought $100 of HQY stock 10 years ago, it would be worth $369.17 today based on a ...

Perlin covers the Technology sector, focusing on stocks such as Broadridge Financial Solutions, Fiserv, and NCR Voyix. According to TipRanks, Perlin has an average return of -10.5% and a 37.63% ...

Our fair value estimate is 60% higher than HealthEquity's analyst price target of US$111 Today we will run through one way of estimating the intrinsic value of HealthEquity, Inc. (NASDAQ:HQY) by ...

HealthEquity, Inc. (NASDAQ:HQY), a Nasdaq-listed company and member of the top Nasdaq stocks, is making strides in the ...

HealthEquity HQY has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 14.06%. Currently, HealthEquity has a market capitalization of ...

Debra McCowan was the founder of Accelerance, Inc. (2011) and served as Partner from 2011 to 2013. Ms. McCowan is currently an Independent Director at HealthEquity, Inc. since 2018. Former positions ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% ...

HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 17 million accounts, working in close partnership with employers, benefits advisors, and health ...

HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2026 ...

Shares of HQY stock opened at $84.52 on Wednesday. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ...

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. resulting from allegations that ...